Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product

DRG:HYBRiD-XL: Celiac Diseases

DRG is proud to announce the launch of 4 new assays for the fully automated diagnosis and monitoring of Coeliac Diseases on DRG:HYBRiD-XL®

These test systems are intended for the quantitative determination of IgA or IgG antibodies in human serum/plasma samples.

Anti-tissue Transglutaminase:

  • Anti-tTG IgA  HYE-5894
  • Anti-tTG IgG  HYE-5895

Anti-Deamidated Gliadin Peptide:

  • Anti-DGP IgA  HYE-5819
  • Anti-DGP IgG  HYE-5820

Clinical Application:

  • Diagnosis and monitoring of Coeliac Diseases
  • Useful application for diagnosing children

Clear advantages:

  • High sensitivity and good specificity
  • Fully automated sample dilution
  • Good assay performance (validated according to CLSI guidelines)
  • Two controls and two re-calibrators included and ready to use